Evidence map›Paper›PMID 35480484›Full record

ArticleOpen life sciences2022

Potential of honey against the onset of autoimmune diabetes and its associated nephropathy, pancreatitis, and retinopathy in type 1 diabetic animal model.

Sultan Fahad Al Nohair, Syed Suhail Ahmed, Mohamed Saleh Ismail, Ahdab Abdo El Maadawy, Manal A Albatanony, Zafar Rasheed

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Royal Jelly: Biological Action and Health Benefits.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sultan Fahad Al NohairDepartment of Family and Community Medicine, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
Syed Suhail AhmedDepartment of Medical Microbiology, College of Medicine, Qassim University, Buraidah, Qassim, Saudi Arabia.
Mohamed Saleh IsmailDepartment of Nutrition and Food Sciences, Menoufia University, Shebin El-Kom, Egypt.
Ahdab Abdo El MaadawyHome Economics Dept, Faculty of Specific Education, Zagazig University, Zagazig, Egypt.
Manal A AlbatanonyDepartment of Family Medicine, College of Medicine, Qassim University, Unaizah, Saudi Arabia.
Zafar RasheedDepartment of Medical Biochemistry, College of Medicine, Qassim University, P.O. Box 6655, Buraidah-51452, Saudi Arabia.ORCID https://orcid.org/0000-0002-8651-4218
Qassim University · SAMenoufia University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honey has been used as a traditional remedy for various health benefits. This study investigated the potential of honey against the onset of autoimmune diabetes and its associated secondary complications in type 1 diabetic (T1D) experimental animals. Autoimmune diabetes was induced in Sprague Dawley rats, and at the same time, the rats were treated with honey or metformin. Sandwich ELISAs were used to estimate blood glucose, hemoglobin A1C (HbA1c), total cholesterol, and triglycerides. Histopathological examinations determined the T1D-induced lesions on kidneys, pancreas, cornea, and retina. Treatment of rats with honey during the course of T1D induction showed a significant reduction in fasting-blood-glucose and HbA1c (

Indexed as

blood sugardiabetic ratshistopathologyhoneylipid profiletype 1 diabetes

Identifiers

PMID35480484
PMCPMC8989157
OpenAlexW4226232532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.